<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0"
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main" xml:id="_HAUfumG">The Impact of Digital Health Interventions for the Management of Type 2 Diabetes on Health and Social Care Utilisation and Costs: A Systematic Review</title>
				<funder>
					<orgName type="full">National Institute for Health Research Applied Research Collaborations North Thames</orgName>
				</funder>
				<funder>
					<orgName type="full">National Institute for Health and Care Research</orgName>
					<orgName type="abbreviated">NIHR</orgName>
					<idno type="DOI" subtype="crossref">https://doi.org/10.13039/501100000272</idno>
				</funder>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability  status="unknown">
					<licence/>
					<p type="raw">Â© The Author(s) 2022</p>
				</availability>
				<date type="published" when="2022-12-10">10 December 2022</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Tiyi</forename><surname>Morris</surname></persName>
							<email>tiyi.morris@ucl.ac.uk</email>
							<idno type="ORCID">0000-0001-6018-1833</idno>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Department of Applied Health Research , Institute of Epidemiology and Health Care , University College London , 1-19 Torrington Place , London WC1E 7HB , UK</note>
								<orgName type="department" key="dep1">Department of Applied Health Research</orgName>
								<orgName type="department" key="dep2">Institute of Epidemiology and Health Care</orgName>
								<orgName type="institution">University College London</orgName>
								<address>
									<addrLine>1-19 Torrington Place</addrLine>
									<postCode>WC1E 7HB</postCode>
									<settlement>London</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Fiona</forename><surname>Aspinal</surname></persName>
							<email>fionaaspinalf.aspinal@ucl.ac.uk</email>
							<idno type="ORCID">0000-0003-3170-7570</idno>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Department of Applied Health Research , Institute of Epidemiology and Health Care , University College London , 1-19 Torrington Place , London WC1E 7HB , UK</note>
								<orgName type="department" key="dep1">Department of Applied Health Research</orgName>
								<orgName type="department" key="dep2">Institute of Epidemiology and Health Care</orgName>
								<orgName type="institution">University College London</orgName>
								<address>
									<addrLine>1-19 Torrington Place</addrLine>
									<postCode>WC1E 7HB</postCode>
									<settlement>London</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jean</forename><surname>Ledger</surname></persName>
							<email>j.ledger@ucl.ac.uk</email>
							<idno type="ORCID">0000-0003-2523-7971</idno>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Department of Applied Health Research , Institute of Epidemiology and Health Care , University College London , 1-19 Torrington Place , London WC1E 7HB , UK</note>
								<orgName type="department" key="dep1">Department of Applied Health Research</orgName>
								<orgName type="department" key="dep2">Institute of Epidemiology and Health Care</orgName>
								<orgName type="institution">University College London</orgName>
								<address>
									<addrLine>1-19 Torrington Place</addrLine>
									<postCode>WC1E 7HB</postCode>
									<settlement>London</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Keyi</forename><surname>Li</surname></persName>
							<email>keyi.li.19@ucl.ac.uk</email>
							<idno type="ORCID">0000-0003-3852-4312</idno>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Department of Applied Health Research , Institute of Epidemiology and Health Care , University College London , 1-19 Torrington Place , London WC1E 7HB , UK</note>
								<orgName type="department" key="dep1">Department of Applied Health Research</orgName>
								<orgName type="department" key="dep2">Institute of Epidemiology and Health Care</orgName>
								<orgName type="institution">University College London</orgName>
								<address>
									<addrLine>1-19 Torrington Place</addrLine>
									<postCode>WC1E 7HB</postCode>
									<settlement>London</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Manuel</forename><surname>Gomes</surname></persName>
							<email>m.gomes@ucl.ac.uk</email>
							<idno type="ORCID">0000-0002-1428-1232</idno>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Department of Applied Health Research , Institute of Epidemiology and Health Care , University College London , 1-19 Torrington Place , London WC1E 7HB , UK</note>
								<orgName type="department" key="dep1">Department of Applied Health Research</orgName>
								<orgName type="department" key="dep2">Institute of Epidemiology and Health Care</orgName>
								<orgName type="institution">University College London</orgName>
								<address>
									<addrLine>1-19 Torrington Place</addrLine>
									<postCode>WC1E 7HB</postCode>
									<settlement>London</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
							<affiliation key="aff0">
								<note type="raw_affiliation"><label>1</label> Department of Applied Health Research , Institute of Epidemiology and Health Care , University College London , 1-19 Torrington Place , London WC1E 7HB , UK</note>
								<orgName type="department" key="dep1">Department of Applied Health Research</orgName>
								<orgName type="department" key="dep2">Institute of Epidemiology and Health Care</orgName>
								<orgName type="institution">University College London</orgName>
								<address>
									<addrLine>1-19 Torrington Place</addrLine>
									<postCode>WC1E 7HB</postCode>
									<settlement>London</settlement>
									<country key="GB">UK</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main" xml:id="_unJuYjT">The Impact of Digital Health Interventions for the Management of Type 2 Diabetes on Health and Social Care Utilisation and Costs: A Systematic Review</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2022-12-10">10 December 2022</date>
						</imprint>
					</monogr>
					<idno type="MD5">927097B07ADA4297774C14D8A7CF47C6</idno>
					<idno type="DOI">10.1007/s41669-022-00377-9</idno>
					<note type="submission">Accepted: 26 September 2022 /</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-08-31T08:50+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">a91ee48</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=2, consolidateHeader=2, consolidateFunders=1, includeRawAffiliations=true, includeRawCitations=true, includeRawCopyrights=true, generateTeiIds=true, generateTeiCoordinates=[all], sentenceSegmentation=true, flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0" xml:id="_W984nPt"><p xml:id="_ezDXmf4"><s xml:id="_tZEpEqF">Background Digital health interventions such as smartphone applications (mHealth) or Internet resources (eHealth) are increasingly used to improve the management of chronic conditions, such as type 2 diabetes mellitus.</s><s xml:id="_vjzAz8C">These digital health interventions can augment or replace traditional health services and may be paid for using healthcare budgets.</s><s xml:id="_9FrrBxG">While the impact of digital health interventions for the management of type 2 diabetes on health outcomes has been reviewed extensively, less attention has been paid to their economic impact.</s><s xml:id="_2MQWSY6">Objective This study aims to critically review existing literature on the impact of digital health interventions for the management of type 2 diabetes on health and social care utilisation and costs.</s><s xml:id="_ev68vPD">Methods Studies that assessed the impact on health and social care utilisation of digital health interventions for type 2 diabetes were included in the study.</s><s xml:id="_dCmkT7D">We restricted the digital health interventions to information provision, self-management and behaviour management.</s><s xml:id="_jD7Mxjb">Four databases were searched (MEDLINE, EMBASE, PsycINFO and EconLit) for articles published between January 2010 and March 2021.</s><s xml:id="_XA2wxNz">The studies were analysed using a narrative synthesis approach.</s><s xml:id="_h9fD22c">The risk of bias and reporting quality were appraised using the ROBINS-I checklist.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_fEycyN7">Results</head><p xml:id="_szhQ6rT"><s xml:id="_8GvbNEQ">The review included 22 studies.</s><s xml:id="_C2sQhAq">Overall, studies reported mixed evidence on the impact of digital health interventions on health and social care utilisation and costs, and suggested this impact differs according to the healthcare utilisation component.</s><s xml:id="_VdGp65R">For example, digital health intervention use was associated with lower medication use and fewer outpatient appointments, whereas evidence on general practitioner visits and inpatient admissions was mixed.</s><s xml:id="_UYXhp4t">Most reviewed studies focus on a single component of healthcare utilisation.</s><s xml:id="_9tmH8xD">Conclusions The review shows no clear evidence of an impact of digital health interventions on health and social care utilisation or costs.</s><s xml:id="_UyyDrWE">Further work is needed to assess the impact of digital health interventions across a broader range of care utilisation components and settings, including social and mental healthcare services.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<facsimile>
		<surface n="1" ulx="0.0" uly="0.0" lrx="595.276" lry="790.866"/>
		<surface n="2" ulx="0.0" uly="0.0" lrx="595.276" lry="790.866"/>
		<surface n="3" ulx="0.0" uly="0.0" lrx="595.276" lry="790.866"/>
		<surface n="4" ulx="0.0" uly="0.0" lrx="595.276" lry="790.866"/>
		<surface n="5" ulx="0.0" uly="0.0" lrx="595.276" lry="790.866"/>
		<surface n="6" ulx="0.0" uly="0.0" lrx="595.276" lry="790.866"/>
		<surface n="7" ulx="0.0" uly="0.0" lrx="595.276" lry="790.866"/>
		<surface n="8" ulx="0.0" uly="0.0" lrx="595.276" lry="790.866"/>
		<surface n="9" ulx="0.0" uly="0.0" lrx="595.276" lry="790.866"/>
		<surface n="10" ulx="0.0" uly="0.0" lrx="595.276" lry="790.866"/>
		<surface n="11" ulx="0.0" uly="0.0" lrx="595.276" lry="790.866"/>
	</facsimile>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1" xml:id="_TNDebE2">Introduction</head><p xml:id="_wnrr79E"><s xml:id="_xenxg6S">The number of digital health interventions (DHIs) delivered through devices such as smartphones, tablets or computers has increased exponentially <ref type="bibr" target="#b22">[1]</ref>.</s><s xml:id="_3trdQec">Such DHIs have been used to facilitate remote access to effective treatments, improve the management of chronic conditions and promote healthy behaviours.</s><s xml:id="_dRnEjuu">Previous systematic reviews have synthesised evidence about the impact of DHIs on health outcomes and patient experience <ref type="bibr" target="#b23">[2,</ref><ref type="bibr" target="#b24">3]</ref>.</s><s xml:id="_BuYJ8HM">However, the economic impact of DHIs is less well understood.</s><s xml:id="_ckuR4At">On the one hand, one might expect DHIs to be cost saving because they may help deliver healthcare more efficiently.</s><s xml:id="_uutc2Xn">On the other hand, the implementation of DHIs may imply large investments by the health system, for example, restructuring care pathways and health services, implementation costs and staff training and upskilling.</s><s xml:id="_9Xdh6DH">While economic evidence is rapidly emerging, the overall direction and magnitude of the economic impact of DHIs is unclear.</s></p><p xml:id="_GW5bqVA"><s xml:id="_hDNeDEX">One of the areas where DHIs have received considerable attention is the management of type 2 diabetes <ref type="bibr" target="#b25">[4]</ref>.</s><s xml:id="_ekJkb5G">Digital health interventions are particularly valuable in this context because they can facilitate the management of the condition and encourage behavioural change (e.g.</s><s xml:id="_9N2y76g">diet and exercise) <ref type="bibr" target="#b26">[5]</ref>.</s><s xml:id="_W49WesS">Studying the economic impact of DHIs in type 2 diabetes is crucial because the burden of disease is large <ref type="bibr" target="#b27">[6]</ref>, and hence, there is ample scope to deliver more health gains from scarce health and social care resources.</s><s xml:id="_KpHFyTG">A recent study <ref type="bibr" target="#b28">[7]</ref> reviewed cost-effectiveness analyses of DHIs for the prevention and control of type 2 diabetes but the focus was on DHIs delivered through smartphones and included decision-analytical modelling studies.</s></p><p xml:id="_ycCYATX"><s xml:id="_SbVnmpN">Our study aims to critically review the impact of DHIs for the management of type 2 diabetes across a broad range of health and social care services and their associated costs.</s><s xml:id="_cCHFjxf">The review focuses on DHIs that seek to promote or manage health and well-being through supporting behavioural change and decision making of the patient diagnosed with type 2 diabetes, sometimes in combination with a healthcare professional.</s><s xml:id="_PHQu6gg">In this population, DHIs may be used for the management of the long-term condition.</s><s xml:id="_ccp2ET4">Such interventions are typically interactive, personalised, based on user input and may be provided at the individual or population level.</s><s xml:id="_wYdcFNN">This review aims to generate a deeper understanding of the economic impacts (on individuals and health systems) of more complex types of DHIs.</s><s xml:id="_5NAyrba">Simpler forms of DHIs, such as diagnostic and monitoring devices, are much closer to the nature of conventional medical devices, and their economic impact has been reviewed elsewhere <ref type="bibr" target="#b29">[8]</ref>.</s><s xml:id="_QeA7Umg">While we focus on a single long-term condition, we anticipate a similar economic impact of DHIs that support behavioural change and decision making across other chronic conditions, such as arthritis or heart disease.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2" xml:id="_9U5MuvV">Methods</head><p xml:id="_ZrmaKST"><s xml:id="_bQc57Jq">The review protocol was registered on PROSPERO (CRD42020172621) <ref type="bibr" target="#b30">[9]</ref>.</s><s xml:id="_s7jAahG">The review includes quantitative assessments of the economic impact of DHIs for type 2 diabetes.</s></p><p xml:id="_gsURGEW"><s xml:id="_3zNTnQe">Studies met the inclusion criteria for this review if:</s></p><p xml:id="_SPUWV9q"><s xml:id="_e7aYKXu">1. they included a population of adults (aged 18 years and above) with type 2 diabetes who had received a DHI for information provision, self-management or behaviour management; 2. comparators were standard care, or information provision or group information sessions, no comparator or other DHIs; 3. the outcomes considered were health and social care utilisation and cost; 4. they were evaluations undertaken in a public or private clinical setting internationally; and 5. they were reported in journal articles published in English.</s></p><p xml:id="_VmFCgeN"><s xml:id="_eArDaqk">Studies were excluded if they were studying a patient population with type 1 diabetes, gestational or other rarer forms of diabetes, or the DHI was focussed on comorbidities or complications of type 2 diabetes.</s><s xml:id="_4agB6au">They were also excluded if clinicians alone used the interventions, for example decision-support systems, and if the study outcomes were only cost-effectiveness modelling (not including patient-level data) or patient experience or satisfaction alone, not including reporting of health and social care utilisation and costs.</s></p><p xml:id="_3XJeCkP"><s xml:id="_f4zmK5s">Four databases, MEDLINE, EMBASE, PsycINFO and EconLit, were searched for articles published between January 2010 and March 2021.</s><s xml:id="_8YXzHJp">A search strategy was developed in MEDLINE with the help of an information specialist to ensure proper use of search terms.</s><s xml:id="_EZ5K4Q6">This strategy was adapted for use in the other databases.</s><s xml:id="_X5WCYJg">Appendix 1 shows the search strategy for all databases.</s><s xml:id="_VDUZPxJ">It combined key terms about DHIs, type 2 diabetes and the economic impact in terms of health and social care utilisation and costs.</s></p><p xml:id="_5xP8skQ"><s xml:id="_5TQ94sg">The database searches were run in April 2021.</s><s xml:id="_naQuZQs">Duplicates were removed using the Rayyan web application <ref type="bibr" target="#b31">[10]</ref> and Endnote referencing software <ref type="bibr">[11]</ref>.</s><s xml:id="_mMp6KTU">The first reviewer screened all the records using Microsoft Excel.</s><s xml:id="_tfd5MTC">A second reviewer screened 20% of the included abstracts and full texts for eligibility.</s><s xml:id="_GabWjv9">Any disputes were discussed between the first and second reviewers.</s><s xml:id="_VKRDSbq">If the conflicts remained, they were referred to a third reviewer.</s></p><p xml:id="_pqFZ7aQ"><s xml:id="_FGJEwA3">Templates for data extraction were piloted and adapted to enable key data to be extracted from the included papers.</s><s xml:id="_TDxRqmS">Information was extracted on the characteristics of the studies (i.e.</s><s xml:id="_mHuFVtD">number of participants and participant characteristics, country, study type, length of follow-up, key outcome measures reported and their results), the impact on health and social care utilisation (e.g.</s><s xml:id="_eg3RSfY">self-reported or administrative data source changes in several types of health and social care utilisation) and the resulting impact on costs (e.g.</s><s xml:id="_7X8Bm5X">how cost had changed in the reported follow-up period).</s><s xml:id="_rbMsSzD">The data extraction was reviewed by the third reviewer for quality assurance.</s><s xml:id="_b4f8He5">The review results were analysed using a narrative synthesis approach, in which themes were identified within the study results that related to the aims of the study <ref type="bibr" target="#b32">[12]</ref>.</s><s xml:id="_96P2B2A">Because of the heterogeneity of the study designs and outcomes measures, it was not possible to perform a meta-analysis.</s></p><p xml:id="_CBMkjXd"><s xml:id="_6ASCCps">The ROBINS-I tool <ref type="bibr" target="#b33">[13]</ref> was used to appraise all papers by the first reviewer and all studies were also appraised by a second reviewer.</s><s xml:id="_eGYbTm8">It is a quality assessment checklist designed to assess the overall risk of biases in the study design and analysis, including aspects related to: (1) confounding; (2) sample selection; (3) classification and measurement error; (4) deviations from study protocol; (4) missing data; and (5) reporting.</s><s xml:id="_HjkqC2b">Within each of these components, studies can be rated as 'low risk of bias' (comparable to a well-conducted randomised controlled trial [RCT]), 'moderate risk of bias' (sound for a non-randomised trial, but not comparable to a RCT), 'serious risk of bias' (the study has some significant issues that may affect the validity of the results), 'critical risk of bias' (too problematic to provide any useful evidence) and 'no information' (no information on which to base a judgement) if the design or analysis component has not been reported.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3" xml:id="_RxwhtGs">Results</head><p xml:id="_tRVAhK3"><s xml:id="_wzH7utw">The results of the searches are shown in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flowchart (Fig. <ref type="figure" target="#fig_0">1</ref>).</s><s xml:id="_CqaYgBA">The database searches identified 617 papers after removing duplicates.</s><s xml:id="_fu4sazu">These papers were then screened and assessed for eligibility.</s><s xml:id="_R8SU6x5">The reasons for papers to be excluded are outlined in the PRISMA flowchart.</s><s xml:id="_mDqPNBC">During abstract screening, many studies were excluded because they focused on a non-relevant DHI (n = 157).</s><s xml:id="_vk3ZDJ6">For example, they did not consider a DHI at all, or focused on medical devices for type 2 diabetes and interventions that were targeted at clinicians such as decision support systems.</s><s xml:id="_dPhD4Ww">Others were excluded because they did not consider impacts on healthcare utilisation and costs (n = 159), focused on other types of diabetes or targeted complications (e.g.</s><s xml:id="_9ucwuJe">foot ulcers) of type 2 diabetes (n = 53).</s><s xml:id="_p878fQK">Systematic reviews synthesising the impact of DHIs on health outcomes and patient experience were also excluded (n = 51).</s></p><p xml:id="_2JxtGA6"><s xml:id="_KFNEDHw">At full-text screening, studies were excluded mainly because they did not evaluate the impact on healthcare utilisation and costs (n = 25), did not focus on type 2 diabetes (n = 9) or were not an impact study (n = 7).</s><s xml:id="_cUP9sSt">Twenty-two studies were included in the review.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.1" xml:id="_7NxZ5Zq">Study Characteristics</head><p xml:id="_DudjtGq"><s xml:id="_3Ahkx9f">The key study characteristics are shown in Table <ref type="table" target="#tab_0">1</ref>.</s><s xml:id="_RVQVzaA">Most studies (n = 16, 73%) had over 100 participants and were conducted in North America (n = 8, 36%) or Europe (n = 9, 41%).</s><s xml:id="_mgpkDVf">Over half of the studies (n = 13, 59%) were conducted alongside RCTs.</s><s xml:id="_26BQ4wD">Almost half of the studies (n = 10, 45%) involved a comparison of DHI with treatment as usual, although this meant a variety of face-to-face services across a range of settings (e.g.</s><s xml:id="_dvGufvf">primary and secondary care).</s><s xml:id="_qnhEsa6">Most studies considered relatively short follow-up periods: five (23%) had a follow-up of up to 6 months and 14 studies (64%) had a follow-up of 6-12 months.</s></p><p xml:id="_AGnqKzb"><s xml:id="_VbyQbUz">Most studies considered the impact of DHIs on a single component of healthcare utilisation or costs.</s><s xml:id="_GJ3K5z7">For example, eight studies reported the impact on medication utilisation (e.g.</s><s xml:id="_rUGBjsJ">metformin or insulin) <ref type="bibr">[14]</ref><ref type="bibr">[15]</ref><ref type="bibr">[16]</ref><ref type="bibr">[17]</ref><ref type="bibr">[18]</ref><ref type="bibr">[19]</ref><ref type="bibr">[20]</ref><ref type="bibr">[21]</ref>.</s><s xml:id="_cH6AumS">A measurement of HbA1c over 6.5% corresponds to a diagnosis of type 2 diabetes, and management of the condition includes targeting a level of HbA1c below 7%.</s><s xml:id="_D6wXbXQ">Five of these were studies in which most patients had HbA1c levels between 7 and 9% <ref type="bibr">[14]</ref><ref type="bibr">[15]</ref><ref type="bibr">[16]</ref><ref type="bibr">[17]</ref><ref type="bibr">[18]</ref> and the rest had populations where the mean HbA1c level was higher.</s><s xml:id="_TWbKNRx">In the studies where the time since onset was recorded, patients varied from 'newly diagnosed' to later stages of the disease requiring insulin or treatment intensification.</s></p><p xml:id="_RwAqCn6"><s xml:id="_4RZPvWm">Very few studies (n = 3, 17%) reported an impact across several primary and secondary care utilisation components <ref type="bibr">[22]</ref><ref type="bibr">[23]</ref><ref type="bibr">[24]</ref>, which included a mix of hospital, general practitioner (GP) and community diabetes-related services.</s><s xml:id="_YVU8jVG">Eight (36%) of the studies were based on self-management (patients monitoring their lifestyle and condition alone) <ref type="bibr">[14,</ref><ref type="bibr">16,</ref><ref type="bibr">22,</ref><ref type="bibr">[24]</ref><ref type="bibr" target="#b45">[25]</ref><ref type="bibr">[26]</ref><ref type="bibr">[27]</ref><ref type="bibr">[28]</ref> and eight more on behaviour management (patients and professionals managing patients' lifestyle and condition) <ref type="bibr">[15,</ref><ref type="bibr">17,</ref><ref type="bibr">20,</ref><ref type="bibr">21,</ref><ref type="bibr">[29]</ref><ref type="bibr">[30]</ref><ref type="bibr">[31]</ref><ref type="bibr">[32]</ref>.</s><s xml:id="_p3qMaWj">Four (18%) were based on self-management and information provision together <ref type="bibr">[18,</ref><ref type="bibr">19,</ref><ref type="bibr">33,</ref><ref type="bibr">34]</ref>, one (5%) on behaviour and self-management <ref type="bibr">[23]</ref>, and another on behaviour management and information provision <ref type="bibr">[35]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.2" xml:id="_Q387kHA">Summary of Study Results</head><p xml:id="_GYTywRZ"><s xml:id="_NKN2BGD">The study results are summarised in Table <ref type="table">2</ref>. Overall, the direction of the impact of DHIs on health and social care utilisation was mixed, irrespective of the mode of delivery of the DHIs.</s><s xml:id="_t7fzdZA">Four (18%) studies reported an increase in healthcare utilisation <ref type="bibr">[20]</ref><ref type="bibr">[21]</ref><ref type="bibr">[22]</ref><ref type="bibr">33]</ref>, seven (32%) studies suggested a reduction in care utilisation <ref type="bibr">[16,</ref><ref type="bibr">18,</ref><ref type="bibr">24,</ref><ref type="bibr">27,</ref><ref type="bibr">28,</ref><ref type="bibr">30,</ref><ref type="bibr">34]</ref>, and five (23%) studies reported both positive and negative economic impacts <ref type="bibr">[17,</ref><ref type="bibr" target="#b45">25,</ref><ref type="bibr">26,</ref><ref type="bibr">31,</ref><ref type="bibr">32]</ref>.</s><s xml:id="_rrtacYN">Of those studies that reported costs (n = 7, 31%), six suggested a decrease in costs <ref type="bibr">[15,</ref><ref type="bibr">19,</ref><ref type="bibr">24,</ref><ref type="bibr">28,</ref><ref type="bibr">29,</ref><ref type="bibr">35]</ref>, and one reported increased costs <ref type="bibr">[23]</ref>.</s><s xml:id="_mJ5UC53">The magnitude of the cost impact in these studies was relatively small, usually less than $500 saving per patient over a time horizon of 6-12 months.</s></p><p xml:id="_XVdAdhy"><s xml:id="_v6MRf8D">The reviewed studies suggest that the impact of DHIs might differ according to the component of healthcare utilisation.</s><s xml:id="_PWKmkyn">For example, DHIs were mostly associated with lower medication use <ref type="bibr">[14-21, 28, 31, 36]</ref> and fewer outpatient visits <ref type="bibr">[25, 28-32, 34, 35]</ref>.</s><s xml:id="_evNtH4e">In the studies where the time since onset was recorded, patients varied from 'newly diagnosed' to later stages of the disease requiring insulin or treatment intensification.</s><s xml:id="_RSEs8nN">Whereas, the impact of DHIs on GP visits <ref type="bibr" target="#b45">[25,</ref><ref type="bibr">26,</ref><ref type="bibr">28,</ref><ref type="bibr">30,</ref><ref type="bibr">32,</ref><ref type="bibr">35]</ref>, hospital accident and emergency <ref type="bibr" target="#b45">[25]</ref><ref type="bibr">[26]</ref><ref type="bibr">[27]</ref><ref type="bibr">32]</ref> and inpatient admission <ref type="bibr" target="#b45">[25,</ref><ref type="bibr">27,</ref><ref type="bibr">30,</ref><ref type="bibr">35]</ref> was mixed.</s><s xml:id="_H2Tv3eE">In studies that reported impacts across multiple healthcare components and settings of care, the evidence was also mixed <ref type="bibr">[22]</ref><ref type="bibr">[23]</ref><ref type="bibr">[24]</ref><ref type="bibr">35]</ref>.</s><s xml:id="_Z2tA2pX">None of the studies reported impacts on social care or mental healthcare utilisation.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.3" xml:id="_EF9eFXc">Quality Assessment</head><p xml:id="_YcStjN2"><s xml:id="_J6RjpBR">Results of the quality assessment are shown in Table <ref type="table" target="#tab_2">3</ref>. Overall, the risk of bias was relatively low across the reviewed studies <ref type="bibr" target="#b33">[13]</ref>.</s><s xml:id="_CAG8ysZ">Across the studies included, the most common issues were a lack of appropriate analysis methods for confounding, and missing data (lack of follow-up data for much of the original sample because of a high dropout, or a lack of information about methods for adjusting for missing data).</s></p><p xml:id="_Wc9J8rp"><s xml:id="_E2cgZZM">Twelve (55%) RCTs were included in the analysis <ref type="bibr">[15-17, 19, 23-26, 29, 32, 34, 35]</ref> with the vast majority being judged 'low risk' in all categories.</s><s xml:id="_JnX7hVs">The remaining ten (45%) <ref type="bibr">[14, 18, 20-22, 27, 28, 30, 31, 33]</ref> studies were non-randomised, with three of them being rated 'high risk' because of potential issues with confounding <ref type="bibr">[22,</ref><ref type="bibr">27,</ref><ref type="bibr">30]</ref>.</s><s xml:id="_nE575Rf">Two studies were judged as having 'moderate risk' <ref type="bibr">[20,</ref><ref type="bibr">30]</ref> because of sample selection issues.</s><s xml:id="_6cxa4wB">Two of the observational studies provided insufficient information on missing data <ref type="bibr">[21,</ref><ref type="bibr">31]</ref> and were classified as 'no information'.</s><s xml:id="_pkNS87V">Records identified through database searching (n = 629) Records after duplicates removed (n = 617) Records screened (n = 617) Records excluded (n = 543) Not digital health (n = 157) Not type 2 diabetes (n = 53) Comorbidity/ complication (n=31) Systematic review (n=51) Not an evaluation (n =31) Outside years of interest (n = 6) Not patient-facing (n= 11) Age of target group (n= 9) Research proposal (n= 19) Discussion paper/ commentary (n=16) Not healthcare utilisation (n = 159) Records assessed for eligibility (n =74) Total studies included in review (n = 22) Records excluded (n = 52) Not digital health (n=4) Not type 2 diabetes (n=9) Not healthcare utilisation (n=25) Not an evaluation (n=7) Commentary (n=1) Not patient-facing (n =1) Discussion paper (n=2) Not in English (n=3) Records removed before screening Duplicate records removed (n = 12)</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4" xml:id="_ZG3k3wr">Discussion</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.1" xml:id="_K3EsgAm">Summary of Findings</head><p xml:id="_cruy4xk"><s xml:id="_yqedUJU">This study critically assessed published evidence on the economic impact of DHIs for type 2 diabetes on health and social care utilisation and costs.</s><s xml:id="_sY7mxsc">Overall, the review suggests that the direction of the impact of DHIs on healthcare utilisation is mixed and might differ according to the healthcare utilisation component.</s><s xml:id="_HthjUcV">In particular, DHIs seem to be associated with a reduction in medication and fewer diabetes-related outpatient appointments.</s><s xml:id="_UGgbDB8">The vast majority of studies evaluating the impact of DHIs on healthcare costs reported a decrease in costs.</s><s xml:id="_X4t968N">The overall risk of biases in the reviewed studies is relatively low; the vast majority of the non-randomised studies was rated 'low' or 'moderate' risk across most bias components.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.2" xml:id="_TKM9p9p">Contributions</head><p xml:id="_SjZpR3e"><s xml:id="_jTRPETb">This is the first study to comprehensively review the economic impact of DHIs for type 2 diabetes.</s><s xml:id="_9SUb2e2">Overall, our review suggests that the case for an economic benefit is not as clear as the clinical benefit shown in previous systematic reviews <ref type="bibr" target="#b24">[3,</ref><ref type="bibr" target="#b57">37]</ref>.</s><s xml:id="_q2HpPPa">The study also shows that the existing evidence base is limited because of the short follow-ups of many studies evaluating interventions for type 2 diabetes, and the difficulty in comparing heterogeneous results for the impact on service utilisation and costs.</s><s xml:id="_cXe5pg8">We have also shown that studies report a limited number of cost dimensions and do not show a benefit as clearly in the costliest types of care (e.g.</s><s xml:id="_szQvBAE">hospital admissions).</s><s xml:id="_sM75FWd">However, the studies have included participants at a range of various stages of the disease in terms of the time since diagnosis and the duration of type 2 diabetes symptoms (which may or may not be linked).</s></p><p xml:id="_pJtqKNs"><s xml:id="_FRaJNe8">A recent study <ref type="bibr" target="#b28">[7]</ref> reviewed the cost-effectiveness evidence on mHealth interventions for type 2 diabetes and suggested that, overall, these tend to provide good value for money.</s><s xml:id="_cCUpWUS">This does not necessary mean that the mHealth interventions considered in that study led to lower costs as they can be cost effective even if they are more costly than the comparator.</s><s xml:id="_AuhC7fU">However, this review <ref type="bibr" target="#b28">[7]</ref> focused on (modelling-based) cost-effectiveness analyses, and interventions delivered through smartphones, whereas our study included a broader range of DHIs and all types of economic impact evaluations.</s><s xml:id="_TjHZ6FC">By reviewing a more comprehensive range of impact studies, we find that the economic impact of DHIs may not be as well understood as suggested by the previous review.</s></p><p xml:id="_uDYPeUZ"><s xml:id="_uYTVGtx">Our review also found that the economic impact of DHIs might differ across the different types of healthcare utilisation.</s><s xml:id="_m3TmMZ9">In fact, it suggests that potential economic benefits are most likely to materialise in certain care components such as medication and insulin use, or outpatient attendances <ref type="bibr">[15,</ref><ref type="bibr">16,</ref><ref type="bibr">18,</ref><ref type="bibr">19,</ref><ref type="bibr">29,</ref><ref type="bibr">34]</ref>.</s><s xml:id="_TyMnK8Z">Unlike previous reviews <ref type="bibr" target="#b28">[7]</ref>, our study considered the impact of DHIs on both health and social care utilisation and costs, but found no evidence on the impact on social, community and informal care services.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.3" xml:id="_aVX8QXR">Limitations</head><p xml:id="_AQeGXwF"><s xml:id="_ZndtvDV">One of the limitations of this review is that it did not consider grey literature or studies published in languages other than English.</s><s xml:id="_bpUsFBA">It was deemed important to include high-quality evidence and full evaluations such as RCTs and large</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_9AySCFu">Medication and outpatient</head><p xml:id="_rFZCavm"><s xml:id="_CHkgBYk">Mixed observational studies on the impacts of digital health, which are less likely to be reported outside journal articles.</s></p><p xml:id="_zGqn5Sb"><s xml:id="_EJSQFXZ">Our study was not able to disentangle potential drivers of the impact of DHIs on health and social care utilisation and costs.</s><s xml:id="_QhNDPGX">Characteristics such as age, duration of disease, ethnicity or gender may have an impact on clinical and economic outcomes, but the reviewed studies have not considered whether the economic impact of DHIs varies across these factors.</s><s xml:id="_tbXVPXZ">One notable exception is the evaluation of the HeLP-Diabetes programme, which adjusted for age and disease duration in the economic analysis <ref type="bibr">[24]</ref>.</s><s xml:id="_J9SbcSd">Poduval et al.'s qualitative analysis as part of the same study finds that the shorter the duration of diabetes since diagnosis, the greater the likelihood of completing an intervention <ref type="bibr" target="#b58">[38]</ref>, and hence the higher the costs incurred.</s></p><p xml:id="_CSCPx7P"><s xml:id="_sThmk5U">The mix of results found in this review may have been partially explained by differences in care pathways and health financing systems across the different countries included in the review.</s><s xml:id="_JCpfsDj">However, this review was not able to disentangle this, and determine whether the findings are generalisable across jurisdictions.</s><s xml:id="_wuun2kc">In addition, this review was not able to dissect whether the economic impact of DHIs differs according to whether the DHI complements or substitutes face-to-face health services.</s><s xml:id="_p9W3cw5">The heterogeneity of DHI types in terms of their function (self-management or behaviour management as defined previously) did not appear to have a clear effect on the impact of DHIs.</s><s xml:id="_2SuUj2u">However, the proportion of DHIs reducing service use or cost was slightly higher in DHIS for self-management (seven out of 12) <ref type="bibr">[16,</ref><ref type="bibr">18,</ref><ref type="bibr">19,</ref><ref type="bibr">24,</ref><ref type="bibr">27,</ref><ref type="bibr">28,</ref><ref type="bibr">34]</ref> than when service users used the DHIs with healthcare professionals <ref type="bibr">[15,</ref><ref type="bibr">29,</ref><ref type="bibr">30,</ref><ref type="bibr">35]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.4" xml:id="_ccc9rsG">Implications for Future Research</head><p xml:id="_V7ptMmY"><s xml:id="_E9dKKbX">This review has identified some gaps in the literature about the impact of digital health for type 2 diabetes on healthcare utilisation.</s><s xml:id="_PpNak2y">First, DHIs are likely lead to a broad range of health and non-health cost impacts, including those outside the healthcare sector <ref type="bibr" target="#b59">[39]</ref>.</s><s xml:id="_qYVGdXK">Hence, studies should account for the potential economic impact across a broader range of sectors, such as social and community care settings, informal care and productivity impacts.</s><s xml:id="_Qy9B8hb">Second, DHI software updates and iterations are an important consideration that has received little attention in the reviewed studies.</s><s xml:id="_ysea2Ar">Because digital health is a rapidly moving field, DHIs are likely to be updated during an evaluation.</s><s xml:id="_JSbVd83">As a result, the interventions themselves may change during an evaluation and it will be important to assess the extent to which the evolving nature of DHIs impacts on health and social care utilisation.</s><s xml:id="_5UbbehD">Third, further work is warranted to explore which type of patients benefit most from these DHIs and which elements of the DHIs drive this (e.g.</s><s xml:id="_YFJGZEe">therapeutic elements or dose), and how this heterogeneity may impact health and social</s></p><formula xml:id="formula_0">DHI digital health intervention, RCT randomised controlled trial</formula><p xml:id="_yNJxb7S"><s xml:id="_R6a6CWZ">Table 2 (continued) First author (year) Country N Study design Follow-up Intervention approach Mode of delivery Control Health and social care utilisation category Effect on health are utilisation Effect on cost Nicolucci (2015) Italy 302 RCT 12 months Self-management/ information provision Web Usual care Outpatient Decrease Roelofsen (2016) The Netherlands 633 Prospective observational 12 months Self-management/ information provision Web Other DHI Medication Decrease Warren (2018) Australia 126 RCT 6 months Behaviour man-agement/information provision Tablet and web Usual care Primary, outpatient, emergency and inpatient Decrease Decrease Wild (2016) UK 307 RCT 9 months Behaviour management Web Usual care Primary and emergency Mixed Yu (2020) Taiwan 97 Prospective observational 8 months Self-management App None Medication, primary and outpatient Decrease Decrease</s></p><p xml:id="_HbKCsNz"><s xml:id="_hzDQeaA">care utilisation.</s><s xml:id="_buVgfvS">This is important so that adaptations and iterations of DHIs target the populations that are most likely to benefit from the DHIs and lead to greater savings to the health system.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5" xml:id="_rErtgbn">Conclusions</head><p xml:id="_zrwKsqh"><s xml:id="_8EwjTJ2">The review found mixed evidence on the economic impact of DHIs.</s><s xml:id="_ek76f3Q">Reviewed studies suggested that this impact might differ according to the care component, with DHIs being associated with a reduction in medication and diabetesrelated outpatient appointments, but not GP visits or hospital admissions.</s><s xml:id="_Mb5RWue">Future work should consider exploring the economic impact of DHIs across a broader range of care components and settings, and whether this impact is mediated by patient or contextual factors.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_B5r6dzS">Appendix 1: Search strategies MEDLINE</head><p xml:id="_JSN9fgc"><s xml:id="_VGKZSjs">1 "diabetes mellitus, type 2"/ or "adult onset diabetes mellitus".mp.</s><s xml:id="_fS3C6K9">or "type 2 diabetes".mp.</s><s xml:id="_YEx4XBT">or "t2dm".mp. 2 "Mobile applications"/ or "Telemedicine"/ or "Mobile application*".mp.</s><s xml:id="_ea5Kab3">or "Telemedicine".mp.</s><s xml:id="_58d4yjd">or "Digital Health".mp. or "App* on prescription".mp.</s><s xml:id="_y2DTywD">or "app".</s><s xml:id="_7dChHQS">mp. or "Digital prescribing".mp.</s><s xml:id="_xkAGA67">or "Wearable*".mp.</s><s xml:id="_yJVCMEv">or "Digital Therapeutic*".mp. or ("Digital" adj5 "Medicine").mp.</s><s xml:id="_XvfyYUG">or "blood glucose monitoring".mp.</s><s xml:id="_sw9VTE3">or "internet".mp.</s><s xml:id="_mQyHHz8">or "mHealth".mp.</s><s xml:id="_EGX7jDQ">or "eHealth".mp.</s><s xml:id="_N5yMU2E">or "remote delivery".mp.</s><s xml:id="_fTgY2KB">or "online".mp.</s><s xml:id="_Nx8XU54">or "website".mp. 3 "Health Resources"/ or "health expenditures"/ or "health care use".mp.</s><s xml:id="_9xsm6zW">or "health care utili?ation".mp.</s><s xml:id="_xMupNx3">or "health service use".mp.</s><s xml:id="_wEDCwEN">or "health service utili?ation".mp.</s><s xml:id="_NdxzFgW">or  <ref type="bibr" target="#b45">[25]</ref> "social care use".mp.</s><s xml:id="_NJma8R8">or "social care utili?ation".mp.</s><s xml:id="_uVFpSPw">or "social service use".mp.</s><s xml:id="_6CARDJk">or "health care cost*".mp.</s><s xml:id="_vv3kVy2">or "health care expenditure".mp.</s><s xml:id="_PE3YWSf">or "medical cost*".mp.</s><s xml:id="_XmVm8rm">or "medical expenditure".mp.</s><s xml:id="_vh4hbRU">or "primary care cost*".</s><s xml:id="_QqNw8PV">mp. or "hospital care cost*".mp.</s><s xml:id="_CZsB3D3">or "health care visit*".</s><s xml:id="_yq35dGq">mp. or "medical consultation*".mp.</s><s xml:id="_4e4s7YA">or "medical appointment*".mp.</s><s xml:id="_n7mxaKA">or "doctor visit*".mp.</s><s xml:id="_UCyBJg5">or "GP visit*".mp.</s></p><p xml:id="_fqnd7JE"><s xml:id="_s8Qhd6S">or "hospital outpatient visit*".mp.</s><s xml:id="_8r7Jsh4">or "hospital admission*".mp.</s><s xml:id="_Mb9gdHy">or "specialist visit*".mp.</s><s xml:id="_uVn3p2P">or "specialist referral*".mp.</s><s xml:id="_dFtwwED">or "help-seeking".mp.</s><s xml:id="_zqQkbBV">or "medication".mp.</s><s xml:id="_uURJQna">or "insulin use".mp.</s><s xml:id="_6rDD3kj">or "diabetic medicine*".mp.</s><s xml:id="_39jcg27">or "blood glucose-lowering drug*".mp.</s><s xml:id="_jWp9pXv">or "blood sugar-lowering drug*".mp. 4 1 and 2 and 3 5 limit 4 to dt=20100101-20210331 6 limit 5 to (english language and humans) 7 limit 6 to journal article 8 remove duplicates from 7 EMBASE 1 "Type 2 Diabetes".ti,ab,kw.</s><s xml:id="_t3QyUcw">or "Non Insulin Dependent Diabetes Mellitus"/ or "Adult Onset Diabetes".ti,ab,kw.</s><s xml:id="_gK7dvCR">or "t2dm".</s><s xml:id="_8uHAj4z">ti,ab,kw.</s><s xml:id="_EwNPMBp">2 "Mobile application"/ or "Mobile application*".ti,ab,kw.</s></p><p xml:id="_TTEYgCY"><s xml:id="_uSVv9ZR">or "Telemedicine*".ti,ab,kw.</s><s xml:id="_Ku4MbxT">or "Telemedicine"/ or "Digital Health".ti,ab,kw.</s><s xml:id="_RvnbBXe">or "app".ti,ab,kw.</s><s xml:id="_bm5cXhv">or "App* on prescription".ti,ab,kw.</s><s xml:id="_jkP3Kvu">or "Digital prescribing".</s><s xml:id="_SA5pSep">ti,ab,kw.</s><s xml:id="_G3nHemp">or "Wearable*".ti,ab,kw.</s><s xml:id="_bAkB9yn">or "Digital Therapeutic*".ti,ab,kw.</s><s xml:id="_djeU8Hb">or ("Digital" adj5 "Medicine").ti,ab,kw.</s></p><p xml:id="_Qb7eBSJ"><s xml:id="_BUJgZf6">or "blood glucose monitoring".ti,ab,kw.</s><s xml:id="_yPhN4fp">or "mHealth".</s><s xml:id="_Ur3nzZb">ti,ab,kw.</s><s xml:id="_AMvnDQA">or "eHealth".ti,ab,kw.</s><s xml:id="_Jhs3rTn">or "remote delivery".</s><s xml:id="_p3URMcK">ti,ab,kw.</s><s xml:id="_VGcwYhA">or "online".ti,ab,kw.</s><s xml:id="_B3J2P2d">or "website".ti,ab,kw.</s><s xml:id="_fE5jZNU">or "internet".ti,ab,kw.</s></p><p xml:id="_FMZrcPT"><s xml:id="_dhjwWsa">3 "health care utilisation"/ or "health care delivery"/ or "health care cost"/ or "healthcare expenditure*".</s><s xml:id="_PfMBj7q">ti,ab,kw.</s><s xml:id="_SRtNMQ3">or "health care use".ti,ab,kw.</s><s xml:id="_dyy6JRT">or "health care utili#ation".ti,ab,kw.</s><s xml:id="_dFbdAF2">or "health care cost*".ti,ab,kw.</s><s xml:id="_YhFQhKD">or "health expenditure*".ti,ab,kw.</s><s xml:id="_CepmEjH">or "health service use".</s><s xml:id="_g3GQC5U">ti,ab,kw.</s><s xml:id="_ekpAPJU">or "health care utili#ation".ti,ab,kw.</s><s xml:id="_pKS2dr2">or "social care use".ti,ab,kw.</s><s xml:id="_MjepDeg">or "social care utili#ation".ti,ab,kw.</s><s xml:id="_NZdqvrN">or "social service use".ti,ab,kw.</s><s xml:id="_PFkCdtq">or "health care expenditure*".ti,ab,kw.</s><s xml:id="_P5Ck2JZ">or "medical cost*".ti,ab,kw.</s><s xml:id="_VHfeZZc">or "medical expenditure*".ti,ab,kw.</s><s xml:id="_KnBW2Rx">or "primary care cost*".ti,ab,kw.</s><s xml:id="_wDfSyvG">or "hospital care cost*".ti,ab,kw.</s><s xml:id="_tgzRXmv">or "health care visit*".</s><s xml:id="_qdWpsNs">ti,ab,kw.</s><s xml:id="_tHmX9BV">or "medical consultation*".ti,ab,kw.</s><s xml:id="_CmJbjEN">or "medical appointment*".ti,ab,kw.</s><s xml:id="_vKEknCB">or "doctor visit*".ti,ab,kw.</s><s xml:id="_uctq6CM">or "GP visit*".ti,ab,kw.</s><s xml:id="_vawWhUw">or "hospital outpatient visit*".</s><s xml:id="_73axDFC">ti,ab,kw.</s><s xml:id="_njsrbyz">or "hospital admission*".ti,ab,kw.</s><s xml:id="_EBu7T7w">or "specialist visit*".ti,ab,kw.</s><s xml:id="_XnqhSSS">or "specialist referral*".ti,ab,kw.</s><s xml:id="_KyaKhnK">or "help-seeking".ti,ab,kw.</s><s xml:id="_Ru4vzJh">or "medication*".ti,ab,kw.</s><s xml:id="_a4sTr72">or "insulin use".ti,ab,kw.</s><s xml:id="_jJVq72h">or "diabetic medicine*".ti,ab,kw.</s></p><p xml:id="_cYFed2b"><s xml:id="_tt9waVC">or "blood glucose-lowering drug*".ti,ab,kw.</s><s xml:id="_aU7hjqB">or "blood sugar-lowering drug*".ti,ab,kw.</s><s xml:id="_4Zk33Hd">or "medical spending".</s><s xml:id="_YK5jZ4d">ti,ab,kw.</s><s xml:id="_t29wHKr">or "service use".ti,ab,kw.</s><s xml:id="_EjbTswv">or "health resource*".</s><s xml:id="_Pf84seu">ti,ab,kw.</s><s xml:id="_9BVSZBD">4 1 and 2 and 3 5 limit 4 to dc=20100101-20210331 6 limit 5 to (human and english language) 7 limit 6 to (article and journal) 8 remove duplicates from 7 PsychInfo 1 exp "Type 2 Diabetes"/ or "Adult Onset Diabetes".mp.</s></p><p xml:id="_jbkc9Kc"><s xml:id="_9AdsHea">or "diabetes mellitus type 2".mp.</s><s xml:id="_RQw5hww">or "type 2 diabetes".</s><s xml:id="_b9CFaA4">mp. or "t2dm".mp. 2 exp "Mobile Applications"/ or "Mobile Application*".</s><s xml:id="_QTSpBux">mp. or exp "Computer Applications"/ or "Telemedicine".</s><s xml:id="_z8QPZru">mp. or exp "Telemedicine"/ or "Digital Health".mp. or exp "Digital Interventions"/ or "Digital Prescribing".</s><s xml:id="_fXQqHA5">mp. or exp "Wearable Devices"/ or " App* on prescription ".mp.</s><s xml:id="_MYDMCbF">or " app".mp.</s><s xml:id="_nJxqg5k">or "Digital Therapeutic*".mp. or ("Digital" adj5 "Medicine").mp.</s><s xml:id="_mCeZDH7">or "blood glucose monitoring".mp.</s><s xml:id="_ghzWZuS">or "internet".mp.</s><s xml:id="_VEvQqaj">or "mHealth".mp.</s><s xml:id="_awxDeRP">or "eHealth".mp.</s><s xml:id="_yMbaa8u">or "remote delivery".mp.</s><s xml:id="_GfDhw9d">or "online".mp.</s><s xml:id="_UTtVb5S">or "website".mp. 3 exp "Health Care Utilization"/ or exp "Health Care Services"/ or exp "Health Care Costs"/ or "Health Care Cost*".mp. or "health expenditure*".mp.</s><s xml:id="_UTb3cpQ">or "medical spending".mp.</s><s xml:id="_b8bbyTE">or "Health Resource*".mp. or "health care use".mp.</s><s xml:id="_ARSX525">or "health service use".mp.</s><s xml:id="_ynycAzF">or "health service utili#ation".mp.</s><s xml:id="_2h9gyxv">or "social care use".mp.</s><s xml:id="_fV9NMTn">or "social care utili#ation".mp.</s><s xml:id="_WKBFjyt">or "social service use".mp.</s><s xml:id="_XwDCR5d">or "health care expenditure*".mp.</s><s xml:id="_qp3Zwb4">or "medical cost*".mp.</s><s xml:id="_g6v3Uqs">or "medical expenditure*".mp.</s><s xml:id="_qvDxDqS">or "primary care cost*".</s><s xml:id="_GS6p2gT">mp. or "hospital care cost*".mp.</s><s xml:id="_3cm9cTy">or "health care visit*".</s><s xml:id="_7AmcndG">mp. or "medical consultation*".mp.</s><s xml:id="_SzuyTBa">or "medical appointment*".mp.</s><s xml:id="_hvY6PYV">or "doctor visit*".mp.</s><s xml:id="_jsjAYZz">or "GP visit*".mp.</s><s xml:id="_UPsUGEF">or "hospital outpatient visit*".mp.</s><s xml:id="_tMAGubp">or "hospital admission*".mp.</s><s xml:id="_aR2mURP">or "specialist visit*".mp.</s><s xml:id="_YtMuP2m">or "specialist referral*".mp.</s><s xml:id="_AaV6AJp">or "help-seeking".mp.</s><s xml:id="_E9KNh3Z">or "medication*".mp.</s><s xml:id="_MCxAshA">or "insulin use".mp.</s><s xml:id="_2wpPqQP">or "diabetic medicine*".mp.</s><s xml:id="_YgbjP97">or "blood glucose-lowering drug*".mp.</s><s xml:id="_Jy7Y6CG">or "blood sugar-lowering drug*".mp. 4 1 and 2 and 3 5 limit 4 to up="20100101-20210331" 6 limit 5 to (human and english language) 7 limit 6 to journal article 8 remove duplicates from 7</s></p><p xml:id="_b7yysqM"><s xml:id="_R5PgeCp">EconLit 1 TX diabetes mellitus type 2 or type 2 diabetes or t2dm or adult-onset diabetes 2 TX mobile application?</s><s xml:id="_wMbuVN2">or telemedicine or mobile application?</s><s xml:id="_PEhcSR6">or app or mobile app? or mhealth or ehealth or digital health or digital medicine or digital prescribing or wearable* or digital therapeutic* or digital medicine or blood glucose monitoring 3 TX health resource utili?ation or health care service?</s><s xml:id="_SduT3jP">or health resource?</s><s xml:id="_pkUPxgu">or medical spending or service use or healthcare utili?ation or health care cost? or outpatient visit?</s><s xml:id="_Euwvbtf">or health care use or health service use or health service utili?ation or social care use or social care utili?ation or social service use or health care expenditure?</s><s xml:id="_s578UWf">or medical cost? or medical expenditure?</s><s xml:id="_KWAUdDM">or primary care cost? or hospital care cost? or health care visit?</s><s xml:id="_fHBVqH8">or medical consultation?</s><s xml:id="_SvgJgHx">or medical appointment?</s><s xml:id="_KgVyPK8">or doctor visit?</s><s xml:id="_tDKNh9U">or GP visit?</s><s xml:id="_bNcpfq4">hospital outpatient visit?</s><s xml:id="_B9DaKma">or hospital admission?</s><s xml:id="_q5nM7gg">or specialist visit?</s><s xml:id="_qqzBZAk">or specialist referral?</s><s xml:id="_m6b6ydG">or help-seeking or medication or insulin use or diabetic medicine or blood glucose-lowering drug? or blood sugar-lowering drug? 4 SR1 OR S2 OR S3 5 Limiters -Published Date: 20100101-20210331 Declarations</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Fig. 1</head><label>1</label><figDesc><div><p xml:id="_Z4jTpEj"><s xml:id="_eG27b4a">Fig. 1 Preferred reporting items for systematic reviews and meta-analyses (PRISMA) flowchart</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1</head><label>1</label><figDesc><div><p><s xml:id="_jMj5FAB">Summary of study characteristics *Three studies reported both service use and costs[24, 28, 35]</s></p></div></figDesc><table><row><cell>DHI digital health intervention, RCT randomised controlled trial,</cell></row><row><cell>TAU treatment as usual</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 3</head><label>3</label><figDesc><div><p xml:id="_xAyY4Ea"><s xml:id="_6DRMEs3">Risk of bias</s></p></div></figDesc><table><row><cell>Potential sources of bias</cell></row></table></figure>
		</body>
		<back>

			<div type="funding">
<div xml:id="_WctqA54"><p xml:id="_FS7gtg6"><s xml:id="_nfr9qyJ">Funding <rs type="person">Tiyi Morris</rs> has been funded through a <rs type="funder">National Institute for Health Research Applied Research Collaborations North Thames</rs> PhD studentship.</s><s xml:id="_XDyFFEY">The views expressed in this publication are those of the author(s) and not necessarily those of the <rs type="funder">National Institute for Health Research</rs> or the <rs type="institution">Department of Health and Social Care</rs>.</s></p></div>
			</div>
			<listOrg type="funding">
			</listOrg>

			<div type="availability">
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_QEUGyUs">Availability of data and material Not applicable.</head><p xml:id="_8HkGXZJ"><s xml:id="_upzEqsN">Code availability Not applicable.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0" xml:id="_q2GkQS7"><p xml:id="_pNwtkZy"><s xml:id="_yEwgWDu">Conflicts of interest/competing interests Tiyi Morris, Fiona Aspinal, Jean Ledger, Keyi Li and Manuel Gomes have no conflicts of interest that are directly relevant to the content of this article.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_pnGs3by">Ethics approval Not applicable.</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_gpBJKTs">Consent to participate Not applicable.</head><p xml:id="_TsGvdtW"><s xml:id="_dGdaCNH">Authors' contributions All authors contributed to the study conception and design.</s><s xml:id="_k65Bktr">Material preparation, data collection and analysis were performed by TM, FA, KL and MG.</s><s xml:id="_Jmntww6">The first draft of the manuscript was written by TM and all authors commented on previous versions of the manuscript.</s><s xml:id="_pf2pZHk">All authors read and approved the final manuscript.</s></p><p xml:id="_qcpb9Da"><s xml:id="_sq3sj2k">Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.</s><s xml:id="_tguqKu2">The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material.</s><s xml:id="_sp9NCJV">If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.</s><s xml:id="_vQE7rJy">To view a copy of this licence, visit <ref type="url" target="http://creativecommons.org/licenses/by-nc/4.0/">http:// creat iveco mmons. org/ licen ses/ by-nc/4. 0/</ref>.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Al</forename><surname>Hayek</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Al Hayek (2021)</note>
</biblStruct>

<biblStruct xml:id="b1">
	<monogr>
		<title/>
		<author>
			<persName><surname>Arora</surname></persName>
		</author>
		<idno type="DOI">10.4324/9781315029702</idno>
		<imprint>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Arora (2014)</note>
</biblStruct>

<biblStruct xml:id="b2">
	<monogr>
		<title/>
		<author>
			<persName><surname>Fico</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Fico (2020)</note>
</biblStruct>

<biblStruct xml:id="b3">
	<monogr>
		<title/>
		<author>
			<persName><surname>Fountoulakis</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Fountoulakis (2015)</note>
</biblStruct>

<biblStruct xml:id="b4">
	<monogr>
		<title/>
		<author>
			<persName><surname>Gilmer</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Gilmer (2019)</note>
</biblStruct>

<biblStruct xml:id="b5">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Gordon</forename></persName>
		</author>
		<imprint>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Gordon (2014)</note>
</biblStruct>

<biblStruct xml:id="b6">
	<monogr>
		<title/>
		<author>
			<persName><surname>Katz</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Katz (2012)</note>
</biblStruct>

<biblStruct xml:id="b7">
	<monogr>
		<title/>
		<author>
			<persName><surname>Kempf</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kempf (2017)</note>
</biblStruct>

<biblStruct xml:id="b8">
	<monogr>
		<title/>
		<author>
			<persName><surname>Li</surname></persName>
		</author>
		<idno type="DOI">10.2991/icmess-18.2018.110</idno>
		<imprint>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Li (2018)</note>
</biblStruct>

<biblStruct xml:id="b9">
	<monogr>
		<title/>
		<author>
			<persName><surname>Lorig</surname></persName>
		</author>
		<idno type="DOI">10.1007/978-3-658-10589-1_1</idno>
		<imprint>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Lorig (2016)</note>
</biblStruct>

<biblStruct xml:id="b10">
	<monogr>
		<title/>
		<author>
			<persName><surname>Lu</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Lu (2020)</note>
</biblStruct>

<biblStruct xml:id="b11">
	<monogr>
		<title/>
		<author>
			<persName><surname>Luley</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Luley (2011)</note>
</biblStruct>

<biblStruct xml:id="b12">
	<monogr>
		<title/>
		<author>
			<persName><surname>Maxwell</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Maxwell (2016)</note>
</biblStruct>

<biblStruct xml:id="b13">
	<monogr>
		<title/>
		<author>
			<persName><surname>Mcgloin</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">McGloin (2020)</note>
</biblStruct>

<biblStruct xml:id="b14">
	<monogr>
		<title/>
		<author>
			<persName><surname>Menon</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.nhccr.2017.06.163</idno>
		<imprint>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Menon (2017)</note>
</biblStruct>

<biblStruct xml:id="b15">
	<monogr>
		<title/>
		<author>
			<persName><surname>Musacchio</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.cell.2011.08.001</idno>
		<imprint>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Musacchio (2011)</note>
</biblStruct>

<biblStruct xml:id="b16">
	<monogr>
		<title/>
		<author>
			<persName><surname>Nicolucci</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Nicolucci (2015)</note>
</biblStruct>

<biblStruct xml:id="b17">
	<monogr>
		<title/>
		<author>
			<persName><surname>Roelofsen</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Roelofsen (2016)</note>
</biblStruct>

<biblStruct xml:id="b18">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Warren</forename></persName>
		</author>
		<imprint>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Warren (2018)</note>
</biblStruct>

<biblStruct xml:id="b19">
	<monogr>
		<title/>
		<author>
			<persName><surname>Wild</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Wild (2016)</note>
</biblStruct>

<biblStruct xml:id="b20">
	<monogr>
		<title/>
		<author>
			<persName><surname>Yu</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Yu (2020)</note>
</biblStruct>

<biblStruct xml:id="b21">
	<monogr>
		<title level="m" type="main" xml:id="_Xky47Xm">Key for risk of bias table Critical risk Serious risk Moderate risk Low risk No Information References</title>
		<imprint/>
	</monogr>
	<note type="raw_reference">Key for risk of bias table Critical risk Serious risk Moderate risk Low risk No Information References</note>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main" xml:id="_NJtNjAk">Big tech, big data and the new world of digital health</title>
		<author>
			<persName><forename type="first">J</forename><surname>Thomason</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.glohj.2021.11.003</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_hhrqs7g">Glob Health J</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="165" to="168" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Thomason J. Big tech, big data and the new world of digital health. Glob Health J. 2021;5(4):165-8.</note>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main" xml:id="_jJqwvHM">Effectiveness of mobile health interventions on diabetes and obesity treatment and management: systematic review of systematic reviews</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Min</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Khuri</surname></persName>
		</author>
		<idno type="DOI">10.2196/15400</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_HwwqZTy">JMIR Mhealth Uhealth</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page">15400</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Wang Y, Min J, Khuri J et al. Effectiveness of mobile health interventions on diabetes and obesity treatment and management: systematic review of systematic reviews. JMIR Mhealth Uhealth. 2020;8(4): e15400.</note>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main" xml:id="_hfdrw4d">T2DM self-management via smartphone applications: a systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">M</forename><surname>Cui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_5Hmscwc">PLoS One</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page">166718</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Cui M, Wu X, Mao J, et al. T2DM self-management via smart- phone applications: a systematic review and meta-analysis. PLoS One. 2016;11(11): e0166718.</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main" xml:id="_BTTWGfA">Digital health interventions for diabetes: everything to gain and nothing to lose</title>
		<author>
			<persName><forename type="first">D</forename><surname>Kerr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>King</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Klonoff</surname></persName>
		</author>
		<idno type="DOI">10.2337/ds18-0085</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_FCwuh6G">Diabetes Spectr</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page">226</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kerr D, King F, Klonoff DC. Digital health interventions for dia- betes: everything to gain and nothing to lose. Diabetes Spectr. 2019;32(3):226.</note>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main" xml:id="_8cpmDvf">Digital healthcare intervention to improve self-management for patients with type 2 diabetes: a scoping review</title>
		<author>
			<persName><forename type="first">N</forename><surname>Villalobos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">S</forename><surname>Vela</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Hernandez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_4DvmdXa">J Sci Innov Med</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page">21</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Villalobos N, Vela FS, Hernandez LM. Digital healthcare inter- vention to improve self-management for patients with type 2 dia- betes: a scoping review. J Sci Innov Med. 2020;3(3), p.21</note>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main" xml:id="_QEBCKcV">The economic costs of type 2 diabetes: a global systematic review</title>
		<author>
			<persName><forename type="first">T</forename><surname>Seuring</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Archangelidi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Suhrcke</surname></persName>
		</author>
		<idno type="DOI">10.1007/s40273-015-0268-9</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_F4KYZ9h">Pharmacoeconomics</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="811" to="831" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Seuring T, Archangelidi O, Suhrcke M. The economic costs of type 2 diabetes: a global systematic review. Pharmacoeconomics. 2015;33(8):811-31.</note>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main" xml:id="_F5Gbm2S">Cost and cost-effectiveness of mHealth interventions for the prevention and control of type 2 diabetes mellitus: a systematic review</title>
		<author>
			<persName><forename type="first">G</forename><surname>Rinaldi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hijazi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Haghparast-Bidgoli</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_QzzQkCy">Diabetes Res Clin Pract</title>
		<imprint>
			<biblScope unit="volume">162</biblScope>
			<biblScope unit="page">108084</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Rinaldi G, Hijazi A, Haghparast-Bidgoli H. Cost and cost-effec- tiveness of mHealth interventions for the prevention and control of type 2 diabetes mellitus: a systematic review. Diabetes Res Clin Pract. 2020;162:108084.</note>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main" xml:id="_Kf5Tj9H">Economic evaluation of medical devices</title>
		<author>
			<persName><forename type="first">M</forename><surname>Drummond</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m" xml:id="_be7nP2G">Oxford encyclopedia of economics and finance</title>
		<editor>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Hamilton</surname></persName>
		</editor>
		<meeting><address><addrLine>Oxford</addrLine></address></meeting>
		<imprint>
			<publisher>Oxford University Press</publisher>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Drummond M. Economic evaluation of medical devices. In: Ham- ilton JH, editor. Oxford encyclopedia of economics and finance. Oxford: Oxford University Press; 2018.</note>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main" xml:id="_M3JygV7">The impact of digital health innovations for the management of type II diabetes: a systematic review</title>
		<author>
			<persName><forename type="first">T</forename><surname>Morris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ledger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Aspinal</surname></persName>
		</author>
		<idno>CRD42020172621</idno>
		<ptr target="https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD4202017262" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_MrrGyAs">PROSPERO</title>
		<imprint>
			<date type="published" when="2020-05-11">2020. 2020. 11 May 2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Morris T, Ledger J, Aspinal F, et al. The impact of digital health innovations for the management of type II diabetes: a systematic review. PROSPERO 2020 CRD42020172621. 2020. https:// www. crd. york. ac. uk/ prosp ero/ displ ay_ record. php? ID= CRD42 02017 262. Accessed 11 May 2020.</note>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main" xml:id="_TWsrNug">Rayyan: a web and mobile app for systematic reviews</title>
		<author>
			<persName><forename type="first">M</forename><surname>Ouzzani</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_xxuX3fz">Syst Rev</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="issue">210</biblScope>
			<biblScope unit="page" from="1" to="10" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Ouzzani M, et al. Rayyan: a web and mobile app for systematic reviews. Syst Rev. 2016;5(210):1-10.</note>
</biblStruct>

<biblStruct xml:id="b32">
	<monogr>
		<title level="m" type="main" xml:id="_Q68daDA">Guidance on the conduct of narrative synthesis in systematic reviews: a product from the ESRC Methods Programme</title>
		<author>
			<persName><forename type="first">J</forename><surname>Popay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Roberts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Sowden</surname></persName>
		</author>
		<idno type="DOI">10.13140/2.1.1018.4643</idno>
		<imprint>
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Popay J, Roberts H, Sowden A, et al. Guidance on the conduct of narrative synthesis in systematic reviews: a product from the ESRC Methods Programme. 2006, DOI: 10.13140/2.1.1018.4643</note>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main" xml:id="_mFzFzRM">ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Sterne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>HernÃ¡n</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">C</forename><surname>Reeves</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_aPR8Gts">BMJ</title>
		<imprint>
			<biblScope unit="volume">355</biblScope>
			<biblScope unit="page">4919</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Sterne JA, HernÃ¡n MA, Reeves BC, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355: i4919.</note>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main" xml:id="_XHAZ5xx">User centered design to improve information exchange in diabetes care through eHealth: results from a small scale exploratory study</title>
		<author>
			<persName><forename type="first">G</forename><surname>Fico</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Fioravanti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Beltran-Jaunsaras</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_kNrhRQD">J Med Syst</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">2</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Fico G, Fioravanti A, Beltran-Jaunsaras ME, et al. User centered design to improve information exchange in diabetes care through eHealth: results from a small scale exploratory study. J Med Syst. 2020;44(1):2.</note>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main" xml:id="_Heur97H">A cost-effectiveness analysis of a telephone-linked care intervention for individuals with type 2 diabetes</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">G</forename><surname>Gordon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Bird</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Oldenburg</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.diabres.2013.12.032</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_haszcjw">Diabetes Res Clin Pract</title>
		<imprint>
			<biblScope unit="volume">104</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="103" to="111" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Gordon LG, Bird D, Oldenburg, B, et al. A cost-effectiveness anal- ysis of a telephone-linked care intervention for individuals with type 2 diabetes. Diabetes Res Clin Pract. 2014;104(1):103-11.</note>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main" xml:id="_D5CWY79">Efficacy of the telemedical lifestyle intervention program TeLiPro in advanced stages of type 2 diabetes: a randomized controlled trial</title>
		<author>
			<persName><forename type="first">K</forename><surname>Kempf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Altpeter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Berger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ejnZShv">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="863" to="871" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kempf K, Altpeter B, Berger J, et al. Efficacy of the telemedi- cal lifestyle intervention program TeLiPro in advanced stages of type 2 diabetes: a randomized controlled trial. Diabetes Care. 2017;40(7):863-71.</note>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main" xml:id="_DhXWgZT">Weight loss in obese patients with type 2 diabetes: effects of telemonitoring plus a diet combination: the Active Body Control (ABC) Program</title>
		<author>
			<persName><forename type="first">C</forename><surname>Luley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Blaik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Reschke</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.diabres.2010.11.020</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_cVKbde9">Diabetes Res Clin Pract</title>
		<imprint>
			<biblScope unit="volume">91</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="286" to="292" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Luley C, Blaik A, Reschke K, et al. Weight loss in obese patients with type 2 diabetes: effects of telemonitoring plus a diet combi- nation: the Active Body Control (ABC) Program. Diabetes Res Clin Pract. 2011;91(3):286-92.</note>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main" xml:id="_DqYS7z4">Demographical, clinical, and psychological characteristics of users and nonusers of an online platform for T2DM patients (e-VitaDM-3/ ZODIAC-44)</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Roelofsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Hendricks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Kjj</forename><surname>Van Hateren</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_B3dJAES">J Diabetes Res</title>
		<imprint>
			<biblScope unit="volume">2016</biblScope>
			<biblScope unit="page">6343927</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Roelofsen Y, Hendricks SH, Van Hateren KJJ, et al. Demographi- cal, clinical, and psychological characteristics of users and non- users of an online platform for T2DM patients (e-VitaDM-3/ ZODIAC-44). J Diabetes Res. 2016;2016:6343927.</note>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main" xml:id="_XQNEUym">Internet-based medication management services improve glycated hemoglobin levels in patients with type 2 diabetes</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>He</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_a7Ua6KK">Telemed J E Health</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="686" to="693" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Lu Z, Li Y, He Y, et al. Internet-based medication management services improve glycated hemoglobin levels in patients with type 2 diabetes. Telemed J E Health. 2021;27(6):686-93.</note>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main" xml:id="_UcRwcJP">Evaluation of the impact of a pharmacist-led telehealth clinic on diabetes-related goals of therapy in a veteran population</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">G</forename><surname>Maxwell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Mcfarland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Baker</surname></persName>
		</author>
		<idno type="DOI">10.1002/phar.1719</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Sgv4HMK">Pharmacotherapy</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="348" to="356" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Maxwell LG, McFarland MS, Baker JW et al. Evaluation of the impact of a pharmacist-led telehealth clinic on diabetes-related goals of therapy in a veteran population. Pharmacotherapy. 2016;36(3):348-56.</note>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main" xml:id="_KT9fyHx">A comparison of characteristics of patients seen in a tertiary hospital diabetes telehealth service versus specialist face-to-face outpatients</title>
		<author>
			<persName><forename type="first">A</forename><surname>Menon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Gray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Fatehi</surname></persName>
		</author>
		<idno type="DOI">10.1177/1357633x17733295</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_HhEyT7X">J Telemed Telecare</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="842" to="849" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Menon A, Gray LC, Fatehi F, et al. A comparison of characteris- tics of patients seen in a tertiary hospital diabetes telehealth ser- vice versus specialist face-to-face outpatients. J Telemed Telecare. 2017;23(10):842-9.</note>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main" xml:id="_22g7sVF">Impact of the FreeStyle Libre flash glucose monitoring system on diabetes: self-management practices and glycemic control among patients with type 2 diabetes in Saudi Arabia: a prospective study</title>
		<author>
			<persName><forename type="first">Al</forename><surname>Hayek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Robert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Dawish</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">I</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_eUugbYk">Diabetes Metab Syndr</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="557" to="563" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Al Hayek A, Robert AA, Dawish AI. Impact of the FreeStyle Libre flash glucose monitoring system on diabetes: self-management practices and glycemic control among patients with type 2 diabe- tes in Saudi Arabia: a prospective study. Diabetes Metab Syndr. 2021;15(2):557-63.</note>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main" xml:id="_dMs7M6E">Cost-effectiveness of a technology-enhanced diabetes care management program in Mexico</title>
		<author>
			<persName><forename type="first">T</forename><surname>Gilmer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Burgos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Anzaldo-Campos</forename><surname>Mc</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.vhri.2018.12.006</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_vspykCQ">Value Health Reg Issues</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="41" to="46" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Gilmer T, Burgos JL, Anzaldo-Campos MC, et al. Cost-effec- tiveness of a technology-enhanced diabetes care management program in Mexico. Value Health Reg Issues. 2019;20:41-6.</note>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main" xml:id="_spp8AaZ">Cost-effectiveness of facilitated access to a self-management website, compared to usual care, for patients with type 2 diabetes (help-diabetes): randomized controlled trial</title>
		<author>
			<persName><forename type="first">J</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Parrott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sweeting</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_sEwrnB3">J Med Internet Res</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page">e9256</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Li J, Parrott S, Sweeting M, et al. Cost-effectiveness of facilitated access to a self-management website, compared to usual care, for patients with type 2 diabetes (help-diabetes): randomized con- trolled trial. J Med Internet Res. 2018;20(6): e9256.</note>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main" xml:id="_PB8jndk">Mobile App for improved self-management of type 2 diabetes: multicenter pragmatic randomized controlled trial</title>
		<author>
			<persName><forename type="first">P</forename><surname>Agarwal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Mukerji</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Desveaux</surname></persName>
		</author>
		<idno type="DOI">10.2196/10321</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_9TR3CMy">JMIR mHealth uHealth</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">e10321</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Agarwal P, Mukerji G, Desveaux L, et al. Mobile App for improved self-management of type 2 diabetes: multicenter pragmatic randomized controlled trial. JMIR mHealth uHealth. 2019;7(1): e10321.</note>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main" xml:id="_5KQyApy">Trial to examine text messagebased mHealth in emergency department patients with diabetes (TExT-MED): a randomized controlled trial</title>
		<author>
			<persName><forename type="first">S</forename><surname>Arora</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Peters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Burner</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.annemergmed.2013.10.012</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_fT2Hk29">Ann Emerg Med</title>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="745" to="754" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Arora S, Peters AL, Burner E, et al. Trial to examine text message- based mHealth in emergency department patients with diabetes (TExT-MED): a randomized controlled trial. Ann Emerg Med. 2014;63(6):745-54.e6.</note>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main" xml:id="_TVM2DvP">Lessons from a community-based mHealth diabetes self-management program: &quot;It&apos;s not just about the cell phone</title>
		<author>
			<persName><forename type="first">R</forename><surname>Katz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Mesfin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Barr</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_DBEKvH7">J Health Commun</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="67" to="72" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note>Suppl</note>
	<note type="raw_reference">Katz R, Mesfin T, Barr K. Lessons from a community-based mHealth diabetes self-management program: &quot;It&apos;s not just about the cell phone.&quot; J Health Commun. 2012;17(Suppl. 1):67-72.</note>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main" xml:id="_nHRdzsB">Longitudinal effects of an intergenerational mHealth program for older type 2 diabetes patients in rural Taiwan</title>
		<author>
			<persName><forename type="first">K</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P-J</forename><surname>Lee</surname></persName>
		</author>
		<idno type="DOI">10.1177/0145721720907301</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_BHqDWxB">Diabetes Educator</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="206" to="216" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Yu K, Wu S, Lee P-J, et al. Longitudinal effects of an intergenera- tional mHealth program for older type 2 diabetes patients in rural Taiwan. Diabetes Educator. 2020;46(2):206-16.</note>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main" xml:id="_WZzb82A">Impact and duration effect of telemonitoring on EtabA1c, BMI and cost in insulin-treated diabetes mellitus patients with inadequate glycemic control: a randomized controlled study</title>
		<author>
			<persName><forename type="first">S</forename><surname>Fountoulakis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Papanastasiou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Gryparis</surname></persName>
		</author>
		<idno type="DOI">10.14310/horm.2002.1603</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_wBjF3vM">Hormones</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="632" to="643" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Fountoulakis S, Papanastasiou L, Gryparis A, et al. Impact and duration effect of telemonitoring on EtabA1c, BMI and cost in insulin-treated diabetes mellitus patients with inadequate glycemic control: a randomized controlled study. Hormones. 2015;14(4):632-43.</note>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main" xml:id="_FesZtzZ">Patient empowerment using electronic telemonitoring with telephone support in the transition to insulin therapy in adults with type 2 diabetes: observational, pre-post, mixed methods study</title>
		<author>
			<persName><forename type="first">H</forename><surname>Mcgloin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O'</forename><surname>Connell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Glacken</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename></persName>
		</author>
		<idno type="DOI">10.2196/16161</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_BcXCBNZ">J Med Internet Res</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page">16161</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">McGloin H, O&apos;Connell D, Glacken M, et al. Patient empower- ment using electronic telemonitoring with telephone support in the transition to insulin therapy in adults with type 2 diabetes: observational, pre-post, mixed methods study. J Med Internet Res. 2020;22(5): e16161.</note>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main" xml:id="_n7bChDk">Impact of a chronic care model based on patient empowerment on the management of type 2 diabetes: effects of the SINERGIA programme</title>
		<author>
			<persName><forename type="first">N</forename><surname>Musacchio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Lovagnini</forename><surname>Sher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Giancaterini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename></persName>
		</author>
		<idno type="DOI">10.1111/j.1464-5491.2011.03253.x</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_zCGWZMB">Diabet Med</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="724" to="730" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Musacchio N, Lovagnini Sher A, Giancaterini A, et al. Impact of a chronic care model based on patient empowerment on the man- agement of type 2 diabetes: effects of the SINERGIA programme. Diabet Med. 2011;28(6):724-30.</note>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main" xml:id="_qT9U6q5">The impact of supported telemetric monitoring in people with type 2 diabetes: study protocol for a randomised controlled trial</title>
		<author>
			<persName><forename type="first">S</forename><surname>Wild</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hanley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Lewis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_93S8uxz">Trials</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page">198</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Wild S, Hanley J, Lewis S, et al. The impact of supported telem- etric monitoring in people with type 2 diabetes: study protocol for a randomised controlled trial. Trials. 2013;14:198.</note>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main" xml:id="_jhMrZ3W">Benefits of diabetes self-management for health plan members: a 6-month translation study</title>
		<author>
			<persName><forename type="first">K</forename><surname>Lorig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">L</forename><surname>Ritter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Turner</surname></persName>
		</author>
		<idno type="DOI">10.2196/jmir.5568</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_By7duHN">J Med Internet Res</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page">e164</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Lorig K, Ritter PL, Turner K, et al. Benefits of diabetes self-man- agement for health plan members: a 6-month translation study. J Med Internet Res. 2016;18(6): e164.</note>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main" xml:id="_nYyCHXB">A randomized trial on home telemonitoring for the management of metabolic and cardiovascular risk in patients with type 2 diabetes</title>
		<author>
			<persName><forename type="first">A</forename><surname>Nicolucci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Cercone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Chiriatti</surname></persName>
		</author>
		<idno type="DOI">10.1089/dia.2014.0355</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_JEP4WbT">Diabetes Technol Ther</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="563" to="570" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Nicolucci A, Cercone S, Chiriatti A, et al. A randomized trial on home telemonitoring for the management of metabolic and car- diovascular risk in patients with type 2 diabetes. Diabetes Technol Ther. 2015;17(8):563-70.</note>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main" xml:id="_KBqWd2r">Effects of telemonitoring on glycaemic control and healthcare costs in type 2 diabetes: a randomised controlled trial</title>
		<author>
			<persName><forename type="first">R</forename><surname>Warren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Carlisle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Mihala</surname></persName>
		</author>
		<idno type="DOI">10.1177/1357633x17723943</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ZHM2K5M">J Telemed Telecare</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="586" to="595" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Warren R, Carlisle K, Mihala G, et al. Effects of telemonitoring on glycaemic control and healthcare costs in type 2 diabetes: a ran- domised controlled trial. J Telemed Telecare. 2018;24(9):586-95.</note>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main" xml:id="_yjTRscD">Glycemic outcomes in adults with type 2 diabetes participating in a continuous glucose monitor-driven virtual diabetes clinic: prospective trial</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Majithia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Kuslak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Armento</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename></persName>
		</author>
		<idno type="DOI">10.2196/21778</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_evmWkzF">J Med Internet Res</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page">21778</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Majithia AR, Kuslak CM, Armento Lee A, et al. Glycemic out- comes in adults with type 2 diabetes participating in a continuous glucose monitor-driven virtual diabetes clinic: prospective trial. J Med Internet Res. 2020;22(8): e21778.</note>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main" xml:id="_WYtE4hU">Interventions for self-management of type 2 diabetes: an integrative review</title>
		<author>
			<persName><forename type="first">R</forename><surname>Carpenter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Dichicchio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Barker</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ijnss.2018.12.002</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_yBHTMJk">Int J Nurs Sci</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="70" to="91" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Carpenter R, DiChicchio T, Barker K. Interventions for self-man- agement of type 2 diabetes: an integrative review. Int J Nurs Sci. 2019;6:70-91.</note>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main" xml:id="_nTHkysy">Feasibility, acceptability, and impact of a web-based structured education program for type 2 diabetes: real-world study</title>
		<author>
			<persName><forename type="first">S</forename><surname>Poduval</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Marston</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Hamilton</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_TEjTXN2">JMIR Diabetes</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">e15744</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Poduval S, Marston L, Hamilton F, et al. Feasibility, acceptability, and impact of a web-based structured education program for type 2 diabetes: real-world study. JMIR Diabetes. 2020;5(1): e15744.</note>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main" xml:id="_WjGf6uX">Economic Evaluation of Digital Health Interventions: Methodological Issues and Recommendations for Practice</title>
		<author>
			<persName><forename type="first">M</forename><surname>Gomes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Murray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Raftery</surname></persName>
		</author>
		<idno type="DOI">10.1007/s40273-022-01130-0</idno>
		<ptr target="https://doi.org/10.1007/s40273-022-01130-0" />
	</analytic>
	<monogr>
		<title level="j" xml:id="_GadNVay">PharmacoEconomics</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="367" to="378" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Gomes M, Murray E, Raftery, J. Economic Evaluation of Digital Health Interventions: Methodological Issues and Recommen- dations for Practice. PharmacoEconomics 40, 367-378 (2022). https:// doi. org/ 10. 1007/ s40273-022-01130-0</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
